Insight Molecular Diagnostics

IMDX

Börsenwert 98,5 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	3,89 Mio. $	–	–	–
2	2 Bridgeway Capital Management Houston, Texas	356.000 $	+467.328 $	+5.000	Neu
3	3 Vanguard Group Malvern, Pennsylvania	317.000 $	-28.694 $	-307	-6 %
4	4 BlackRock Institutional Trust San Francisco, California	246.000 $	-110.850 $	-1.186	-26 %
5	MHP 5 Manatuck Hill Partners Westport, Connecticut	244.000 $	+31.218 $	+334	+11 %
6	AG 6 Artal Group Luxembourg	228.000 $	–	–	–
7	7 Goldman Sachs New York	105.000 $	+1.869 $	+20	+1 %
8	8 Destination Wealth Management Walnut Creek, California	74.000 $	+96.737 $	+1.035	Neu
9	9 Geode Capital Management Boston, Massachusetts	53.000 $	-12.992 $	-139	-16 %
10	10 Paloma Partners Greenwich, Connecticut	42.000 $	+54.958 $	+588	Neu
11	11 BlackRock Fund Advisors San Francisco, California	24.000 $	-308.530 $	-3.301	-91 %
12	12 PNC Financial Services Group Pittsburgh, Pennsylvania	14.000 $	–	–	–
13	13 Deutsche Bank Frankfurt Am Main Ge, Germany	9.000 $	+5.047 $	+54	+61 %
14	14 Tower Research Capital (TRC) New York	8.000 $	+5.234 $	+56	+112 %
15	15 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	7.000 $	-8.692 $	-93	-49 %
16	16 Carroll Financial Associates Charlotte, North Carolina	3.000 $	–	–	–
17	17 Morgan Stanley New York	3.000 $	+2.243 $	+24	+96 %
18	18 Royal Bank of Canada Toronto, Ontario, Canada	3.000 $	+2.430 $	+26	+137 %
19	19 BlackRock Investment Management Wilmington, Delaware	2.000 $	-42.340 $	-453	-95 %
20	20 Bank of America Charlotte, North Carolina	2.000 $	-10.281 $	-110	-77 %
21	21 BlackRock Advisors Wilmington, Delaware	2.000 $	-3.739 $	-40	-63 %
22	22 Group One Trading Chicago, Illinois	2.000 $	–	–	–
23	23 Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel	2.000 $	–	–	–
24	24 Creative Planning Overland Park, Kansas	1.000 $	-280 $	-3	-19 %
25	25 Fifth Third Bancorp Cincinnati, Ohio	1.000 $	–	–	–

Insight Molecular Diagnostics IMDX Börsenwert 98,5 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 98,5 Mio. $